Clobazam Oral Suspension Recalled for Failed Stability Specifications
VistaPharm is recalling Clobazam Oral Suspension 2.5 mg/mL due to failed stability specifications. The recall affects 18,456 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The source text does not report any illnesses, injuries, or deaths. The hazard is a manufacturing/stability issue without documented patient harm reported, which aligns with a Moderate rating for a Class II pharmaceutical recall.
Plain-English summary
VistaPharm, Inc. is recalling Clobazam Oral Suspension 2.5 mg/mL in 120 mL bottles due to failed stability specifications. The recalled product is an Rx-only medication manufactured by VistaPharm, Inc. in Largo, Florida (NDC 66689-058-04).
A total of 18,456 bottles have been distributed nationwide within the United States, including Puerto Rico. The recall affects multiple lot numbers with varying expiration dates: Lots 678900, 682000, 682400 (Exp. 5/31/2022); 680600, 680800, 681000 (Exp. 5/30/2022); 683200, 685200 (Exp. 6/30/2022); 728900, 733100 (Exp. 12/31/2022); 738600 (Exp. 1/31/2023); 740600, 741600 (Exp. 2/28/2023); 749800, 750900, 752400 (Exp. 3/31/2023); and 775700 (Exp. 6/30/2023).
Patients and healthcare providers should stop using affected bottles and contact their pharmacy or healthcare provider for guidance on obtaining replacement medication or alternative treatments.
The recalled product
- Product
- Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04
- Manufacturer
- VistaPharm, Inc.
- Category
- Drug — Anticonvulsant
- Hazard
- failed-stability-specifications
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lots #: 678900
- 682000
- 682400
- Exp. 5/31/2022
- 680600
- 680800
- 681000 Exp. 5/30/2022
- 683200
- 685200 Exp. 6/30/2022
- 728900
- 733100 Exp. Date 12/31/2022
- 738600 Exp. 1/31/2023
- 740600
- 741600 Exp. 2/28/2023
- 749800
- 750900
- 752400 Exp. 3/31/2023
- 775700 Exp. 6/30/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27